Elevance: Q3 results improved, but nine-month EPS fell 7.3%
According to TradingView, Elevance's Q3 revenue rose 0.7% and diluted EPS grew 17.9%, while nine-month EPS declined 7.3% on a Medicare accrual.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Elevance Health's third-quarter revenue rose 0.7%, and diluted earnings per share grew 17.9%. For the nine-month period, however, EPS fell 7.3%. The main drag was a $935 million Medicare risk-adjustment accrual, along with a lower operating gain in the Health Benefits segment.
Membership declined 1.1%, while operating cash flow improved to $7.512 billion.
why it matters
For the managed care sector, the trend in medical costs matters most: Medicare-related accruals and pressure on Health Benefits point to risks for insurers' margins. Stronger operating cash flow, however, gives the company more financial flexibility.
market impact
Health insurers: medical-cost and Medicare accrual pressure on margins, affecting ELV and the sector
tags
instruments
sources
- ELV: Q3 earnings improved, but 9M results faced Medicare accrual and medical-cost pressure — TradingView, 21 October 2026 at 18:15 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗